XNAS
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | H1 2026 | — | -1.08 | — | $0 | — | +0.75% | -2.39% | — |
| 2025-06-30 | H1 2025 | — | -0.36 | — | $0 | — | -14.32% | +8.16% | -15.32% |
| 2024-10-25 | FY 2024 |
| — |
| -0.33 |
| — |
| $0 |
| — |
| +31.13% |
| +73.94% |
| +26.96% |
| 2024-06-20 | H1 2024 | — | -0.16 | — | $0 | — | -14.43% | -12.06% | -15.76% |
| 2023-10-27 | FY 2023 | — | -0.45 | — | $0 | — | -3.92% | -13.92% | -33.74% |
| 2023-06-15 | H1 2023 | — | -0.25 | — | $0 | — | -1.76% | +5.10% | -10.17% |
Showing last 6 quarters.